GLYC: GlycoMimetics, Inc. Stock

by  •  • Comments Off on GLYC: GlycoMimetics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 17.29
Enterprise Value ($M) 2.90
Book Value ($M) 11.38
Book Value / Share 0.18
Price / Book 1.52
NCAV ($M) 11.32
NCAV / Share 0.18
Price / NCAV 1.53

Profitability (mra)
Return on Invested Capital (ROIC) -3.41
Return on Assets (ROA) -0.88
Return on Equity (ROE) -1.03

Liquidity (mrq)
Quick Ratio 3.62
Current Ratio 3.62

Balance Sheet (mrq) ($M)
Current Assets 15.65
Assets 15.70
Liabilities 4.32
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-27 13G Logos Global Management LP 7.80
11-12 13G/A Invus Global Management, LLC 3.00 -62.84
11-06 13G Ra Capital Management, L.p. 9.90
11-04 13D Adage Capital Management, L.P. 7.90
11-04 13G/A Weinstein Benjamin
05-08 13D/A New Enterprise Associates 10 L P
02-09 13G/A Artal International S.C.A. 13.30 30.66
2024-01-29 13G/A Biotechnology Value Fund L P 14.80 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 Commission file number 001-36177 GlycoM

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-03 27,923 215,216 12.97
2025-01-31 72,589 219,692 33.04
2025-01-30 436,740 1,043,467 41.85
2025-01-29 82,692 158,941 52.03

(click for more detail)

Similar Companies
GLMD – Galmed Pharmaceuticals Ltd. GLSI – Greenwich LifeSciences, Inc.
GLTO – Galecto, Inc. GNLX – Genelux Corporation
GNPX – Genprex, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: GlycoMimetics